These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 3923647)
21. The interrelationship between thromboxane biosynthesis, aggregation and 5-hydroxytryptamine secretion in human platelets in vitro. Best LC; Holland TK; Jones PB; Russell RG Thromb Haemost; 1980 Feb; 43(1):38-40. PubMed ID: 6773171 [TBL] [Abstract][Full Text] [Related]
22. Effect of acetylsalicylic acid on platelet aggregation and thromboxane B2 production in flowing aortic blood in the rat studied with a filter loop technique. Martin JF; Suggett AJ; Jones PB; Leach E Thromb Res; 1982 Aug; 27(3):251-9. PubMed ID: 6814004 [TBL] [Abstract][Full Text] [Related]
23. Effects of platelet aggregation and adenosine 3':5'-monophosphate on the synthesis of thromboxane B2 in human platelets. Lindgren JA; Claesson HE; Kindahl H; Hammarström S Adv Prostaglandin Thromboxane Res; 1980; 6():275-81. PubMed ID: 6247886 [No Abstract] [Full Text] [Related]
24. Synthesis of thromboxane B2 in uraemia and the effects of dialysis. Winter M; Frampton G; Bennett A; Machin SJ; Cameron JS Thromb Res; 1983 May; 30(3):265-72. PubMed ID: 6868024 [TBL] [Abstract][Full Text] [Related]
25. Modification of platelet aggregation and thromboxane synthesis by intravascular contrast media. Paajanen H; Kormano M; Uotila P Invest Radiol; 1984; 19(4):333-7. PubMed ID: 6434489 [TBL] [Abstract][Full Text] [Related]
26. Effect of endotoxin on arachidonic acid release and thromboxane B2 production by human platelets. Stuart MJ Am J Hematol; 1981 Sep; 11(2):159-64. PubMed ID: 7030066 [TBL] [Abstract][Full Text] [Related]
27. Effects of heparin on platelet aggregation and release and thromboxane A2 production. Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300 [TBL] [Abstract][Full Text] [Related]
28. Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acid. Aharony D; Smith JB; Silver MJ Biochim Biophys Acta; 1982 Oct; 718(2):193-200. PubMed ID: 6814496 [TBL] [Abstract][Full Text] [Related]
29. Mechanisms of vascular graft thrombosis: role of altered canine platelet sensitivity to thromboxane. McGoff MA; Allen BT; Der T; Sicard GA; Santoro SA Thromb Res; 1989 Sep; 55(6):695-707. PubMed ID: 2506670 [TBL] [Abstract][Full Text] [Related]
30. Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex. Di Minno G; Thiagarajan P; Perussia B; Martinez J; Shapiro S; Trinchieri G; Murphy S Blood; 1983 Jan; 61(1):140-8. PubMed ID: 6216929 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens. Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM Thromb Haemost; 1989 Nov; 62(3):996-9. PubMed ID: 2556815 [TBL] [Abstract][Full Text] [Related]
32. 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor. Le Breton GC; Venton DL; Enke SE; Halushka PV Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4097-101. PubMed ID: 291066 [TBL] [Abstract][Full Text] [Related]
33. Synthesis of thromboxane B2 in incubates of dog platelet-rich plasma with arachidonic acid and its inhibition by different drugs. Chignard M; Vargaftig BB; Sors H; Dray F Biochem Biophys Res Commun; 1978 Dec; 85(4):1631-9. PubMed ID: 743319 [No Abstract] [Full Text] [Related]
34. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions. Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of human platelet function in vitro and ex vivo by acetaminophen. Lages B; Weiss HJ Thromb Res; 1989 Mar; 53(6):603-13. PubMed ID: 2499947 [TBL] [Abstract][Full Text] [Related]
36. Arachidonic acid induced platelet aggregation and thromboxane formation is inhibited by OKY-1581. Uotila P; Matintalo M; Dahl ML Prostaglandins Leukot Med; 1983 Nov; 12(3):299-303. PubMed ID: 6419237 [TBL] [Abstract][Full Text] [Related]
37. Suppression by beta-lactam antibiotics of thromboxane A2 generation and arachidonic acid release in rabbit platelets in vitro. Mihara S; Fujimoto M; Okabayashi T Thromb Res; 1986 Nov; 44(3):265-75. PubMed ID: 3798399 [TBL] [Abstract][Full Text] [Related]
38. Requirement of ADP for arachidonic acid-induced platelet aggregation: studies with selective thromboxane-synthase inhibitors. Cerletti C; Minoldo S; Bucchi F; Del Maschio A; de Gaetano G Biochem Pharmacol; 1986 Apr; 35(7):1201-3. PubMed ID: 3083818 [No Abstract] [Full Text] [Related]
39. Megakaryocyte thromboxane production induced by platelet stimuli during in vitro culture. Walenga RW; Miller JL; Stuart MJ Exp Hematol; 1985 Feb; 13(2):87-91. PubMed ID: 3918879 [TBL] [Abstract][Full Text] [Related]
40. Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man. Küster LJ; Frölich JC Prostaglandins; 1986 Sep; 32(3):415-23. PubMed ID: 3097760 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]